Prevention of surgical site infections in low-income and middle-income countries: When more is not better

Affiliations

¹ Service d'Anesthésie Réanimation & Médecine Péri-opératoire, Centre Hospitalier Universitaire de Poitiers, Poitiers, 86021, France; Inserm U1070, Université de Poitiers, Poitiers, France. Electronic address: matthieu.boisson@univ-poitiers.fr.
² Infection Control Programme, Geneva University Hospitals and Faculty of Medicine, Geneva, Switzerland; MRC Centre for Global Infectious Disease Analysis, Imperial College London, London, UK.
³ Service d'Anesthésie, Centre Hospitalier de Versailles, Le Chesnay-Rocquencourt, France.
⁴ Inserm U1070, Université de Poitiers, Poitiers, France; Service des Urgences Adultes & SAMU 86, Centre Hospitalier Universitaire de Poitiers, Poitiers, 86021, France.

Editorial

Matthieu Boisson et al. Anaesth Crit Care Pain Med. 2022 Apr.

. 2022 Apr;41(2):101046.

doi: 10.1016/j.accpm.2022.101046. Epub 2022 Feb 22.

¹ Service d'Anesthésie Réanimation & Médecine Péri-opératoire, Centre Hospitalier Universitaire de Poitiers, Poitiers, 86021, France; Inserm U1070, Université de Poitiers, Poitiers, France. Electronic address: matthieu.boisson@univ-poitiers.fr.
² Infection Control Programme, Geneva University Hospitals and Faculty of Medicine, Geneva, Switzerland; MRC Centre for Global Infectious Disease Analysis, Imperial College London, London, UK.
³ Service d'Anesthésie, Centre Hospitalier de Versailles, Le Chesnay-Rocquencourt, France.
⁴ Inserm U1070, Université de Poitiers, Poitiers, France; Service des Urgences Adultes & SAMU 86, Centre Hospitalier Universitaire de Poitiers, Poitiers, 86021, France.

No abstract available

Keywords: chlorhexidine; low-income and middle-income countries; surgical site infection; triclosan.

Comment on

Chlorhexidine plus alcohol versus povidone iodine plus alcohol, combined or not with innovative devices, for prevention of short-term peripheral venous catheter infection and failure (CLEAN 3 study): an investigator-initiated, open-label, single centre, randomised-controlled, two-by-two factorial trial.
Guenezan J, Marjanovic N, Drugeon B, Neill RO, Liuu E, Roblot F, Palazzo P, Bironneau V, Prevost F, Paul J, Pichon M, Boisson M, Frasca D, Mimoz O; CLEAN-3 trial investigators. Guenezan J, et al. Lancet Infect Dis. 2021 Jul;21(7):1038-1048. doi: 10.1016/S1473-3099(20)30738-6. Epub 2021 Feb 1. Lancet Infect Dis. 2021. PMID: 33539734 Clinical Trial.